News
U.S. Government Exercises 1st Option for Additional 100 Million Doses of Moderna’s COVID-19 Vaccine Candidate
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the...
News
AstraZeneca reports Trixeo Aerosphere approved in EU for COPD maintenance
AstraZeneca’s Trixeo Aerosphere has been approved in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease...
News
SpiceXpress strengthens pharma cold chain capabilities with Om partnership
SpiceXpress, the cargo division of India-based carrier SpiceJet, has partnered with Om Logistics to strengthen its capabilities to transport temperature-sensitive Covid-19 vaccines.
The carrier said the...
Clinical Trials
Sanofi, GSK COVID-19 vaccine rollout delayed on low immune response in older adults
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Phase 1/2 study interim...
News
CHMP recommends approval of Plavix with aspirin in adults for certain types of strokes
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an additional indication for Plavix® (clopidogrel) in...
News
Astrazeneca To Test Combining COVID-19 Vaccine With Russian Shot
Britain's AstraZeneca said on Friday it would investigate combining its experimental COVID-19 vaccine with Russia's Sputnik V vaccine candidate, a move Russian scientists have suggested...
News
Covaxin likely to be available in first quarter of 2021: Bharat Biotech
As companies across the globe are speeding up to bring an effective COVID vaccine, Bharat Biotech’s Joint Managing Director Suchitra Ella hinted that India’s indigenous...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.